Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2023-05-23 00:00:00 ET · period of report 2023-05-18 · accession 0001600620-23-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-23 | 2023-05-18 | AUPH | Hagan Joseph P | Dir | M - OptEx | — | +8,733 | 12.2K | +250% | — |
| D | 2023-05-23 | 2023-05-19 | AUPH | Hagan Joseph P | Dir | S - Sale+OE | $10.58 | -272 | 12.0K | -2% | -$2,878 |
| D | 2023-05-23 | 2023-05-18 | AUPH | Hagan Joseph P | Dir | M - OptEx | $0.00 | -8,733 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | M | A | 8,733 | — | 12,233 | D | — | — | (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date. |
| 2 | Common | Common Stock | 2023-05-19 | S | D | 272 | $10.58 | 11,961 | D | — | — | (F2) Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs. |
| 3 | Derivative | Restricted Stock Units | 2023-05-18 | M | D | 8,733 | $0.00 | 0 | D | — · 2023-05-18 to — | 8,733 Common Stock | (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date. |